77 Capital

77 Capital is an Indian investment syndicate that writes cheques of USD 75,000 to 100,000 into Pre-Seed and Seed stage startups. Its portfolio reflects a clear conviction around B2B software and infrastructure businesses, with investments spanning enterprise and SMB SaaS, B2B marketplaces, fintech, and health tech. Companies like M2P and Hyperface signal comfort with fintech infrastructure and API-led business models, while Clinikally and Fego point to interest in digital health and consumer wellness built on strong tech foundations. Vidyut Tech and Mewt further demonstrate a pattern of backing asset-light, scalable Indian startups solving real enterprise or platform problems. As a syndicate, 77 Capital offers founders more than just capital; the model typically means co-investors and domain-relevant angels come in alongside the lead, which can be valuable for startups seeking both money and market access. Founders pitching to 77 Capital should be prepared to articulate clear unit economics, a defensible B2B go-to-market strategy, and a path to scalable revenue. The typical entry point is early enough to help shape the company, making a crisp product narrative and a strong founding team the most important factors in the conversation.